{"title": "Xia Liu, PhD", "author": null, "url": "https://medicine.uky.edu/users/xli369", "hostname": "medicine.uky.edu", "description": "University of Kentucky College of Medicine", "sitename": "medicine.uky.edu", "date": "2022-10-04", "cleaned_text": "Xia Liu, PhD Connect [859-562-2791](tel:859-562-2791) [xli369@uky.edu](mailto:xli369@uky.edu) Positions - Assistant Professor College Unit(s) Biography and Education Biography Website: xialiulab.com Education Ph.D. in Cancer Biology, Peking Union Medical College & Chinese Academy of Medical Science, China Research Metastasis is responsible for about 90% of cancer-related deaths. The research of my laboratory is focused on understanding the mechanisms of breast cancer metastasis, thereby discovering novel cancer biomarkers and therapeutic targets to improve the treatment for metastatic cancers. Currently, the research projects are mainly focused on understanding the role of neutrophils in breast cancer metastasis, tumor-associated inflammation, how tumor alters granulopoiesis, liquid biomarker discovery and developing novel strategy to improve the efficacy of immune checkpoint inhibitor in TNBC. Selected Publications Research Articles: - Zheng CJ, Xu X, Wu MY, Xue L, Zhu JY, Xia HZ, Ding SY, FU SH, Wang XY, Wang Y, He GC, Liu X (co-corresponding author), Deng XY. Neutrophils in triple-negative breast cancer: an underestimated player with increasingly recognized importance. Breast Cancer Research. 2023, 25:88. - Li D, Hemati H, Park Y, Taftaf R , Zhang YB , Liu JP , Cristofanilli M, Liu X. ICAM-1-suPAR-CD11b Axis Is a Novel Therapeutic Target for Metastatic Triple-Negative Breast Cancer. Cancers, 2023, 15(10): , X( co-corresponding author), Yang JM. Identification of a NACC1-Regulated Gene Signature Implicated in the Features of Triple-Negative Breast Cancer. Biomedicines, 2023, 11(4):1223. - Ramos EK, Tsai CF, Jia Y, Cao Y, Manu M, Taftaf R, Hoffmann AD, El-Shennawy L, Gritsenko MA, Adorno-Cruz V, Schuster EJ, Scholten D, Patel D, Liu X, Patel P, Wray B, Zhang Y, Zhang S, Moore RJ, Mathews JV, Schipma MJ, Liu T, Dashzeveg NK, Liu H. Machine learning-assisted elucidation of CD81-CD44 integrity. 2022 Oct 4;11. - (co-first Singh S, Jia YZ, Dashzeveg NK, Hoffmann L, Ramos EK, Schuster EJ, Scholten D, Patel D, Zhang YB, Davis AA, Reduzzi C, Cao Y, D'Amico P, Shen Y, Cristofanilli M, Muller WA, Varadan V, Liu HP. ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer. Nature Communications. 2021 Aug 11;12(1):4867. - Adorno-Cruz V, Hoffmann AD, Liu X, Dashzeveg NK, Taftaf R, Wray B, Keri RA, Liu H. ITGA2 promotes expression of ACLY and CCND1 in enhancing breast stemness and Dis. 2021 Jul; 8(4): WJ, D, Jia ZH, Liu X, Shi HL, Liu HP. MARCH8 tumor metastasis and mediates degradation of STAT3 and CD44 in breast cancer cells. Cancers, 2021 May 22;13(11):2550. - Tsai CF, Zhang P, Scholten D, Martin K, Wang YT, Zhao R, Chrisler WB, Patel DB, Dou M, Jia Y, Reduzzi C, Liu X, Moore RJ, Burnum-Johnson KE, Lin MH, Hsu CC, Jacobs JM, Kagan Srivastava S, Rodland KD, Steven Wiley H, Qian WJ, Smith RD, Zhu Y, Cristofanilli M, Liu T, Liu H, Shi T. Surfactant-assisted Chang YF, Jia Y, Kawaguchi NK, Taftaf R, Ramos EK, Schuster EJ, El-Shennawy L, D, Zhang Y, Cristofanilli M, Liu H. EGFR inhibition blocks cancer stem cell clustering and lung metastasis of triple negative breast cancer. Theranostics. 2021;11(13):6632-6643. - Wu M, Ma M, Tan Z, Zheng H, Liu X (corresponding author). Neutrophil: A New Player in Metastatic Cancers. Front Immunol. 2020;11: 565165. - Kawaguchi M, Dashzeveg N, Cao Y, Jia Y, Liu X (Lead corresponding author), Shen Y, Liu H. Extracellular Domains I and II of cell-surface glycoprotein CD44 mediate its trans-homophilic dimerization and tumor cluster J Biol Chem. 2020, 295(9):2640-2649. - Liu X (co-corresponding author), Taftaf R, Kawaguchi M, Chang YF, Chen W, Entenberg D, Zhang Y, Gerratana L, Huang S, Patel DB, Tsui E, Adorno-Cruz V, Chirieleison SM, Cao Y, Harney AS, Patel S, A, Avril cell aggregation and polyclonal metastasis in patient-derived breast cancer models. Cancer Discovery. 2019, 9(1):96-113. - Zhang YB, Patel D, Kawaguchi M, Cristofanilli M, Liu HP, Liu X. Lymphomagenesis in circulating tumor cell-derived xenograft models. BJSTR, May 15, 2019, 18(1), 13247- 13249. - Wu M, Tan Z, Ma M, Tao S, Zheng H and Liu X. IKZF2 Driving Self- Renewal and Inhibiting Myeloid Differentiation through Chromatin Accessibility. Journal of Molecular and Genetic Medicine. April 16, 2019, 13:419. - Chen WJ, Hoffmann AD, Liu HP, Liu X. Organotropism: new insights into molecular mechanisms of breast cancer metastasis. npj Precision Oncology. Feb 16, 2018. - Liu X, Zheng H, Li X, Wang S, Meyerson HJ, Yang W, Neel BG, Ptpn11 induced malignancies. PNAS 2016,113 (4):984-9. - Liu X, Zheng H, Yu WM, Cooper TM, Bunting KD, Qu CK. Maintenance of mouse hematopoietic stem cells ex vivo by reprogramming cellular metabolism. Blood. 2015, 125(10):1562-5. - Yu WM, Liu X, Shen J, Jovanovic O, Pohl EE, Gerson SL, Finkel T, Broxmeyer CK. Metabolic regulation by the mitochondrial phosphatase PTPMT1 is required for hematopoietic stem cell differentiation. Cell Stem Cell. 2013, 12 (1):62-74. - Liu X, Zheng H, Qu CK. Protein tyrosine phosphatase Shp2 (Ptpn11) plays an important role in maintenance of chromosome stability. Cancer Res. 2012, 72(20):5296-306. - Liu A, Qu W, Liu X (co-corresponding author), Qu CK. Chromosomal instability in in vitro cultured mouse hematopoietic cells associated with oxidative stress. Am J Blood Res. 2012, 2(1):71-76. - Xu D, Liu X (co-first authorship), Yu WM, Meyerson HJ, Guo C, Gerson SL, Qu CK. Non- of a gain-of-function mutation (Shp2) on malignant transformation of hematopoietic cells. J Exp Med. 2011, 208(10):1977- 88. - Shen J, Liu X (co-first authorship), Yu WM, Liu J, Groot Nibbelink M, Guo C, Finkel T, Qu CK. A critical role of in a embryonic stem cells. Mol Cell Biol. 2011, 31(24):4902-16. Signal Transduct. 2011, 2011:195239. - Liu X, Bian C, Ren K, Jin H, Li B, Shao RG. Lidamycin induces marked G2 cell cycle arrest in human colon carcinoma HT-29 cells through activation of p38 MAPK pathway. Oncol Rep. 2007, 17(3):597-603. - Liu X, He HW, Feng Y, Zhang M, Ren KH, Shao RG. Difference of cell cycle arrests induced by Lidamycin in human breast cancer cells. Anti-cancer drugs. 2006, 17(2):173-179. - Liu X, Su YM. The effects of phenolic alkaloids from Menispermum Dauricum on cell apoptosis and expressions Bcl-2 and Bax in rats following cerebral ischemia- reperfusion. The proceedings of 7th Chinese section meeting of the international society for heart research. 2002. - Tsai CF, Zhang P, Scholten D, Martin K, Wang YT, Zhao R, Chrisler WB, Patel DB, Dou M, Jia Y, Reduzzi C, Liu X, Moore RJ, Burnum-Johnson KE, Lin MH, Hsu CC, Jacobs JM, Kagan Srivastava S, Rodland KD, Steven Wiley H, Qian WJ, Smith RD, Zhu Y, Cristofanilli M, Liu T, Liu H, Shi T. [Surfactant-assisted one-pot preparation S, Law C, Mu L, Khodarev NN, Kim J, Zhao JC, Putzbach W, Murmann AE, Chen Z, Chen W, Liu X, Salomon AR, Liu H, Weichselbaum RR, Yu J, Peter ME. CD95/Fas increases stemness in cancer cells by inducing a STAT1-dependent type I interferonresponse. Cell Rep. 2017, 18(10):2373-2386. - Hu Z, Wang X, Fang H, Liu Y, Chen D, Zhang Q, Liu X, Wei D, Qu C, Wang S. A tyrosine phosphatase SHP2 gain-of-function mutation enhances malignancy of breast carcinoma. Oncotarget. 2016, 7(5):5664-76. - Adorno-Cruz V, Kibria G, Liu X, Doherty M, Junk D, Guan DY, Hubert C,Venere M, Mulkearns- Hubert E, Sinyuk M, Alvarado A, Caplan A,Rich J, Gerson S, Lathia J, Liu HP. Cancer stem cells: targeting the roots of cancer, seeds of metastasis, and sources of therapy resistance. Cancer Res. 2015, 75(6):924-9. - Bockhorn J, Prat A, Chang YF, Liu X, Huang S, Shang M, Nwachukwu C, Gomez-Vega MJ, Harrell JC, Olopade OI, Perou CM, Liu H. Differentiation and loss of malignant character of spontaneous pulmonary metastases in patient-derived breast cancer models. Cancer Res. 2014, 74 (24):7406-17. - Li Q, Hakimi P, Liu X, Yu WM, Ye F, Fujioka H, Raza S, Shankar modulator metabolism murine stem cells. J Biol Chem. 2014, 289(1):251-63. - Ceppi P, Hadji A, Kohlhapp FJ, Pattanayak A, Hau A, Liu X, Liu H, Murmann AE, Peter ME. CD95 and CD95L promote and protect cancer stem cells. Nat Commun. 2014, 5: 5238. - Hnia K, Kretz C, Amoasii B\u00f6hm J, Liu X, Messaddeq N, Qu CK, Laporte J. Primary T- defects JK, Rohrberg TJ, Parelkar NK, Nguyen T, Fuentes Liu of the ryanodine receptor. J Biol Chem. 2010, 285(51):40312-21. - Jin H, Ren K, He HW, Liu X, Song DQ, Shao RG. The benzoylurea derivative F13 inhibits cell growth, migration and invasion through inducing expression of ERK1/2-mediated RECK in fibrosarcoma HT-1080 cells. Anticancer Drugs. 2010, 21(4):372-80. - Ren K, Jin H, Bian C, He H, Liu X, Zhang S, Wang Y, Shao RG. MR-1 modulates proliferation and migration of - Bian CJ, Liu TG, Liu X, Shao RG. Functions of microRNAs in animals. J Med Mol Biol, 2005, 2(5): 359-362. - Yang RQ, Su Protective effects of phenolic alkaloids from Menispermum Dauricum on experimental cerebral ischemia. Information on traditional Chinese medicine. 2002, 19(5):61. Book Chapters - Chopra A, Liu X (co-first authorship), Liu HP. Cancer stem cells: metastasis and evasion from the host immune responses. Cancer stem cells: targeting the roots of cancer, seeds of metastasis, and sources of therapy resistance (chapter 13), 2016, 341-366. - Liu X, Qu CK. SHP-2 tyrosine phosphatase: a potential target for controlling tumor metastasis. New developments in metastasis suppressor "}